HealthNovartis heart drug trial failure leaves doctors seeking evidence for genetic cholesterol target
The recent failure of an experimental Novartis heart drug in a large trial has prompted cardiologists and investors to question whether lowering levels of lipoprotein(a), a genetically determined cholesterol carrier, can improve heart health.
R
Reuters★★★☆☆2026-11-02 16:05Original
Novartis heart drug trial failure leaves doctors seeking evidence for genetic cholesterol target
Health